Orgenesis Inc. announced that it has entered into a purchase agreement and issued 2,000,000 common shares at a price of $0.5 per share for the gross proceeds of $1 million on August 31, 2023.

The company has received $1,000,000 pursuant to Regulation D and included participation from a single investor.